Maartje H. de Groot

Suggest Changes
Learn More
Results from observational studies on inhaled long-acting beta-2-agonists (LABA) and acute myocardial infarction (AMI) risk are conflicting, presumably due to variation in methodology. We aimed to(More)
  • 1